Annual report pursuant to Section 13 and 15(d)

Note 5 - Stock-Based Compensation

v2.4.1.9
Note 5 - Stock-Based Compensation
 12 Months Ended
Dec. 31, 2014
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
5.     STOCK-BASED COMPENSATION
 
On August 18, 2006, the Compensation Committee of Company’s Board of Directors approved, subject to stockholder approval, the Natural Health Trends Corp. 2007 Equity Incentive Plan (the “2007 Plan”). Under the 2007 Plan, the Company may grant (i) incentive stock options, (ii) nonqualified stock options, (iii) restricted stock, (iv) restricted stock units, (v) stock appreciation rights either in tandem with an option or alone and unrelated to an option, or SARs, (vi) performance shares, (vii) award shares, or (viii) stock awards. The 2007 Plan was approved by the Company’s stockholders on November 17, 2006.
 
The purpose of the 2007 Plan is to enable the Company to attract and retain employees, officers, directors, consultants and advisors; to provide an incentive for them to assist in achieving long-range performance goals; and to enable them to participate in the long-term growth of the Company. The terms of any particular grant are determined by the Board of Directors or a committee appointed by the Board of Directors. Generally, the grants of restricted stock vest quarterly on a pro rata basis over a three-year period. The maximum number of shares available for issuance under the 2007 Plan was 1,550,000 shares. At the Company’s Annual Meeting of Stockholders held on December 30, 2008, the Company’s stockholders approved an increase in the maximum number of shares available for issuance under the 2007 Plan by 500,000 shares. As such, the maximum aggregate number of shares available for issuance under the 2007 Plan totals 2,050,000 shares.
As of December 31, 2014, 1,083 shares remain available to be granted under the 2007 Plan.
 
Valuation and Expense Information under FASB ASC Topic 718
 
Stock-based compensation expense totaled approximately $110,000 and $49,000 for 2013 and 2014, respectively. No tax benefits were attributed to the stock-based compensation because a valuation allowance was maintained for substantially all net deferred tax assets.     
 
A following table summarizes the Company’s restricted stock activity under the 2007 Plan:
 
   
Shares
    
Wtd. Avg. Price at Date of Issuance
  
                 
Nonvested at December 31, 2012
     261,658     $ 0.37  
Vested
     (206,672 )     0.37  
Nonvested at December 31, 2013
     54,986       0.37  
Vested
     (54,986 )     0.37  
Nonvested at December 31, 2014
     –       –  
 
On August 13, 2012, the Board of Directors authorized the Company, acting as trustee for certain of its non-officer, overseas employees, to execute a Rule 10b5-1 plan to purchase 100,000 shares of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Exchange Act and the Company's policies regarding stock transactions. 
Pursuant to this authority, the Company, as Trustee, entered into a 10b5-1 plan and began purchasing in December 2012. The latest 10b5-1 plan terminated in November 2014, and the Company, as Trustee, has not entered into a new 10b5-1 plan. The employees will receive the stock as incentive compensation in quarterly increments over three years beginning March 15, 2013, provided that they are employees of the Company on the date of the distribution. Any common stock that is forfeited by an employee whose employment terminates will be delivered to the Company and held as treasury stock.
 
   
Shares
    
Wtd. Avg. Grant-Date Fair Value
  
                 
Nonvested at December 31, 2012
     100,000     $ 1.37  
Vested
     (26,676 )     1.37  
Forfeited
     (20,000 )     1.37  
Nonvested at December 31, 2013
     53,324       1.37  
Vested
     (25,342 )     1.37  
Forfeited
     (3,998 )     1.37  
Nonvested at December 31, 2014
     23,984       1.37  
 
As of December 31, 2014, total unrecognized stock-based compensation expense related to these stock awards was $31,000, which is expected to be recognized over a weighted-average period of one year.